Want to see AU:MX1 full AI Analyst Report?
MX1 Stock Chart & Stats
AU$0.10
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.10
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.12
Previous CloseN/A
Volume191.73K
Average Volume (3M)189.28K
Market Cap
AU$23.94M
Enterprise ValueAU$27.94M
Total Cash (Recent Filing)AU$4.90M
Total Debt (Recent Filing)AU$5.13M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding747,983,000
10 Day Avg. Volume131,613
30 Day Avg. Volume189,275
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)3.96
Price to Sales (P/S)2.29
P/FCF Ratio-3.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.15Price Target Upside50.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$28.90M
Bulls Say, Bears Say
Bulls Say
Proprietary Cold Cathode X-ray TechnologyMicro‑X's carbon nanotube cold cathode X‑ray tube is a durable structural advantage: it enables lighter, portable systems that competitors struggle to replicate. This IP supports product differentiation, recurring tube/component sales, and long sales cycles in defense/medical niches, sustaining revenue potential if commercial execution continues.
Strong Product-level MarginsA ~79% gross margin indicates strong unit economics from the core products, implying pricing power and cost efficiency at the manufacturing level. If Micro‑X controls operating expenses and scales sales, these gross margins create a feasible pathway to sustainable profitability over the medium term.
Diversified End Markets (medical And Security/defence)Serving both medical and security/defence markets provides structural demand diversification: medical imaging offers steady clinical adoption, while defence/security can deliver longer, higher‑margin contracts. This mix reduces single‑market cyclicality and supports steadier long‑term revenue opportunity if commercial penetration improves.
Bears Say
Declining RevenueA nearly 10% revenue decline is a durable concern: shrinking top line reduces scale benefits and impairs the company's ability to absorb fixed costs. Persistent revenue contraction weakens prospects for margin recovery and signals challenges in commercial traction or market penetration that could persist absent clear corrective actions.
Negative Operating And Free Cash FlowNegative operating and free cash flows indicate ongoing cash burn, which erodes runway and forces reliance on external financing. This constrains investments in production scale, R&D, and after‑sales support, raising the risk of dilution or higher borrowing costs and limiting the firm's ability to capitalize on market opportunities.
Rising Leverage And Negative ROEAn increased debt-to-equity ratio (~0.87) combined with negative ROE signals financial strain: higher leverage raises interest burdens and reduces flexibility, while negative ROE reflects shareholder capital erosion. Together these factors heighten solvency risk and may force conservative strategy or asset/liability actions.
Micro-X Ltd. News
MX1 FAQ
What was Micro-X Ltd.’s price range in the past 12 months?
Micro-X Ltd. lowest share price was AU$0.03 and its highest was AU$0.12 in the past 12 months.
What is Micro-X Ltd.’s market cap?
Micro-X Ltd.’s market cap is AU$23.94M.
When is Micro-X Ltd.’s upcoming earnings report date?
Micro-X Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 58 days.
How were Micro-X Ltd.’s earnings last quarter?
Micro-X Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of -AU$0.006 by -AU$0.004.
Is Micro-X Ltd. overvalued?
According to Wall Street analysts Micro-X Ltd.’s price is currently Undervalued.
Does Micro-X Ltd. pay dividends?
Micro-X Ltd. does not currently pay dividends.
What is Micro-X Ltd.’s EPS estimate?
Micro-X Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Micro-X Ltd. have?
Micro-X Ltd. has 747,983,000 shares outstanding.
What happened to Micro-X Ltd.’s price movement after its last earnings report?
Micro-X Ltd. reported an EPS of -AU$0.01 in its last earnings report, missing expectations of -AU$0.006. Following the earnings report the stock price went up 15.385%.
Which hedge fund is a major shareholder of Micro-X Ltd.?
Currently, no hedge funds are holding shares in AU:MX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Micro-X Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.15 (50.00% Upside)
AU$0.15 (50.00% Upside)
Blogger Sentiment
Bullish
AU:MX1 Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$200.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.40%
12-Months-Change
Fundamentals
Return on Equity
-180.06%
Trailing 12-Months
Asset Growth
-12.76%
Trailing 12-Months
Company Description
Micro-X Ltd.
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; Argus, a wide-area scattered projection backscatter and miniaturized high-voltage generator; and space imaging solutions. The company operates in Australia, the United States, the Asia-Pacific, Europe, the Middle East, and Africa. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
MX1 Stock 12 Month Forecast
Average Price Target
AU$0.15
▲(50.00% Upside)
Technical Analysis
Cyclopharm Limited
―
CleanSpace Holdings Ltd.
―
EMvision Medical Devices Ltd.
―
Control Bionics Ltd.
―
4DMedical Ltd
―
Options Prices
Currently, No data available
---